Skip to main content

Table 4 Type and volume of administered fluids and urine output during the first 2 days in ICU

From: Fluid accumulation and major adverse kidney events in sepsis: a multicenter observational study

Fluid type

No MAKE30

(n = 1315)

MAKE30

(n = 519)

No. of patientsa

Median (IQR) volume (ml)b

% of total fluid volumec

No. of patientsa

Median (IQR) volume (ml)b

% of total fluid volumec

Total fluid input

1315

8395 (6233–11,130)

100

519

8559 (6245–11,531)

100

Resuscitation fluids

 Ringer’s solution

1235

3500 (2000–5357)

41.7

481

3460 (2000–5670)

41.0

 Albumin 40 or 50 g/l

359

500 (481–1000)

2.6

139

750 (490–1289)

2.8

 Albumin 200 g/l

498

200 (100 – 348)

1.2

240

200 (100–400)

1.5

 Hydroxyethyl starch

212

963 (500–1014)

1.8

77

1000 (500–1461)

1.7

 Dextran

111

600 (500–1000)

0.8

28

733 (500–1000)

0.6

 Gelofusine

117

1500 (500–2000)

1.4

30

1000 (500–1500)

0.8

 

Proportion of total fluid input from resuscitation fluids

49.5

Proportion of total fluid input from resuscitation fluids

48.4

Non resuscitation fluids

 0.9% saline

1099

432 (152–921)

6.9

451

506 (201–1178)

9.2

 Glucose 25–200 g/l

1283

2106 (1428–2891)

24.3

509

2082 (1316–2954)

23.6

Glucose 300–500 g/l

6

25 (20–40)

 < 0.1

9

30 (20–90)

 < 0.1

 Red blood cells

458

500 (250–750)

2.6

197

500 (250–750)

2.8

 Plasma

342

1000 (500–1750)

4.3

147

750 (500–1500)

3.9

 Platelets

123

600 (300–650)

0.6

100

600 (300–900)

1.5

 Parenteral nutrition

909

182 (12–1096)

5.2

353

112 (11.8–1239)

5.3

 Enteral (oral or nasogastric) fluids

435

710 (325–1300)

3.5

125

425 (200–800)

1.9

 Enteral nutrition (IQR)

345

326 (163–566)

1.4

136

295 (171–495)

1.4

 Electrolyte solutions

1215

78 (36–143)

1.2

474

94 (39–199)

1.6

 Other fluids

109

100 (40–280)

0.3

64

169 (50–462)

0.4

 

Proportion of total fluid input from non-resuscitation fluids

50.5

Proportion of total fluid input from non-resuscitation fluids

51.6

 Total urine output

1305

4215 (2821–6098)

 

511

3081 (1580–4787)

 
  1. aTotal number of patients who received the fluid type presented on each row
  2. bMedian (IQR) delivered volume of each fluid (among those who received the specific fluid type)
  3. cProportion of total fluid intake in the No MAKE30 group and MAKE30 group, respectively